Glenmark Pharma announces Proposed Divestment of Majority Stake in Glenmark Life Sciences
· Glenmark Pharma agrees to divest 75% stake in its subsidiary Glenmark Life Sciences to Nirma Limited, at a price of INR 615/- per share implying an equity valuation of INR 75,354 mn.
!-->!-->!-->…
Read More...
Read More...